CA Patent

CA2604392A1 — Quaternary ammonium halides for treatment of infectious conditions

Assigned to Nanobio Corp · Expires 2006-10-19 · 20y expired

What this patent protects

Compositions comprising quaternary ammonium halides and methods of using the compositions comprising quaternary ammonium halides to treat and/or prevent infectious conditions in humans are provided.

USPTO Abstract

Compositions comprising quaternary ammonium halides and methods of using the compositions comprising quaternary ammonium halides to treat and/or prevent infectious conditions in humans are provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2604392A1
Jurisdiction
CA
Classification
—
Expires
2006-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Nanobio Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.